Retatrutide shows big weight loss potential but isn’t FDA-approved. Here’s what to know about its safety and legal risks.

People taking GLP-1s had reduced risk for atrial fibrillation, regardless of whether they lost weight or how much they lost, ...

The company's new GLP-1 program will offer both oral and injectable medications Courtesy Amazon Amazon has launched a new GLP ...

Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...

The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.

On Tuesday, Amazon unveiled a new GLP-1 management program aimed at simplifying how patients access, and stay on, high-demand ...

The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting ...

April 9 (UPI) --Eli Lilly announced that its GLP-1 weight-loss pill is available for purchase in the United States starting Thursday, little more than a week after the Food and Drug Administration ...

In December, Vanda Pharmaceuticals gained FDA approval for its motion sickness drug Nereus. But a much larger patient population may be in store for the oral therapy as the Washington, D.C.-based ...

Eli Lilly has rolled out Foundayo, its oral GLP-1 pill, directly to consumers through its LillyDirect cash-pay channel, as well as to telehealth providers and pharmacies across the U.S. The drug is a ...